UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __)
MICROMET, INC.
--------------
(Name of Issuer)
Common Stock, Par Value $0.00004 Per Share
------------------------------------------
(Title of Class of Securities)
13738Y107
------------
(CUSIP Number)
December 31, 2006
-----------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE
IS FILED:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
CUSIP No. 13738Y107 13G Page 2 of 9 Pages
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED KINGDOM
--------------------------------------------------------------------------------
5. SOLE VOTING POWER --0--
NUMBER OF ------------------------------------------------
SHARES 6. SHARED VOTING POWER 1,907,390
BENEFICIALLY ------------------------------------------------
OWNED BY EACH 7. SOLE DISPOSITIVE POWER --0--
REPORTING ------------------------------------------------
PERSON WITH 8. SHARED DISPOSITIVE POWER 1,907,390
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,907,390
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE
INSTRUCTIONS) [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.1%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
--------------------------------------------------------------------------------
CUSIP No. 29425Y101 13G Page 3 of 9 Pages
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
SV LIFE SCIENCES MANAGERS LLP
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED KINGDOM
--------------------------------------------------------------------------------
5. SOLE VOTING POWER --0--
NUMBER OF ------------------------------------------------
SHARES 6. SHARED VOTING POWER 1,907,390
BENEFICIALLY ------------------------------------------------
OWNED BY EACH 7. SOLE DISPOSITIVE POWER --0--
REPORTING ------------------------------------------------
PERSON WITH 8. SHARED DISPOSITIVE POWER 1,907,390
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,907,390
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE
INSTRUCTIONS) [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.1%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
--------------------------------------------------------------------------------
CUSIP No. 29425Y101 13G Page 4 of 9 Pages
--------------------------------------------------------------------------------
ITEM 1(a). NAME OF ISSUER:
Micromet, Inc. (the "Issuer")
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
2110 Rutherford Road
Carlsbad, CA 92008
ITEM 2(a). NAME OF PERSON FILING:
This statement is being filed by the following persons:
(i) International Biotechnology Trust plc ("IBT"); and
(ii) SV Life Sciences Managers LLP ("Managers").
IBT and Managers are sometimes individually referred to herein as
a "Reporting Person" and collectively as the "Reporting Persons."
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
Address for IBT:
31 Gresham Street
London, EC2V 7QA
United Kingdom
Address for Managers:
71 Kingsway
London, WC2B 6ST
United Kingdom
ITEM 2(c). CITIZENSHIP:
IBT - United Kingdom
Managers - United Kingdom
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock, par value $0.00004 per share
ITEM 2(e). CUSIP NUMBER:
13738Y107
ITEM 3. Not applicable.
CUSIP No. 29425Y101 13G Page 5 of 9 Pages
--------------------------------------------------------------------------------
ITEM 4. OWNERSHIP.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the Issuer identified in
Item 1.
For IBT and Managers:
(a) Amount beneficially owned: 1,907,390 shares of Common Stock
(b) Percent of class: 6.1%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: --0--
(ii) Shared power to vote or to direct the vote: 1,907,390
(iii) Sole power to dispose or to direct the disposition of:
--0--
(iv) Shared power to dispose or to direct the disposition of:
1,907,390
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
IBT is the record owner of 1,907,390 shares of Common Stock of the
Issuer ("Record Shares"). By virtue of the contractual relationship
between IBT and Managers, Managers may be deemed to own beneficially
the Record Shares. Managers expressly disclaims beneficial ownership
of any shares of such shares of Common Stock.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
CUSIP No. 29425Y101 13G Page 6 of 9 Pages
--------------------------------------------------------------------------------
ITEM 10. CERTIFICATION.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
CUSIP No. 29425Y101 13G Page 7 of 9 Pages
--------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 16, 2007
-----------------
Date
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
/s/ Nick Coleman
--------------------------------------
Signature
Nick Coleman, Authorized Signatory
--------------------------------------
Name/Title
SV LIFE SCIENCES MANAGERS LLP
/s/ Nick Coleman
--------------------------------------
Signature
Nick Coleman, Authorized Signatory
--------------------------------------
Name/Title
CUSIP No. 29425Y101 13G Page 8 of 9 Pages
--------------------------------------------------------------------------------
EXHIBIT INDEX
Exhibit 1. Joint Filing Agreement as required by Rule 13d-1(k)(1) under the
Securities Exchange Act of 1934, as amended.
CUSIP No. 29425Y101 13G Page 9 of 9 Pages
--------------------------------------------------------------------------------
EXHIBIT 1
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)
The undersigned acknowledge and agree that the foregoing statement on Schedule
13G is filed on behalf of each of the undersigned and that all subsequent
amendments to this statement on Schedule 13G shall be filed on behalf of each of
the undersigned without the necessity of filing additional joint filing
statements. The undersigned acknowledge that each shall be responsible for the
timely filing of such amendments, and for the completeness and accuracy of the
information concerning him, her or it contained herein, but shall not be
responsible for the completeness and accuracy of the information concerning the
other entities or persons, except to the extent that he, she or its knows or has
reason to believe that such information is inaccurate.
February 16, 2007
--------------------------------------
Date
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
/s/ Nick Coleman
--------------------------------------
Signature
Nick Coleman, Authorized Signatory
--------------------------------------
Name/Title
SV LIFE SCIENCES MANAGERS LLP
/s/ Nick Coleman
--------------------------------------
Signature
Nick Coleman, Authorized Signatory
--------------------------------------
Name/Title